BDBM551326 8-Chloro-1-(4,4-difluoro-1-methylpyrrolidin-3-yl)-2-{[4-(methoxymethyl)-1H-1,2,3-triazol-1-yl]methyl}-1H-imidazo[4,5-c]quinoline, ENT 1 (22) and 8-Chloro-1-(4,4-difluoro-1-methylpyrrolidin-3-yl)-2-{[4-(methoxymethyl)-1H-1,2,3-triazol-1-yl]methyl}-1H-imidazo[4,5-c]quinoline, ENT 2 (23)::US11312713, Example 23

SMILES COCc1cn(Cc2nc3cnc4ccc(Cl)cc4c3n2[C@@H]2CN(C)CC2(F)F)nn1

InChI Key InChIKey=WYJBFPHJIUFSJH-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 551326   

LigandPNGBDBM551326(8-Chloro-1-(4,4-difluoro-1-methylpyrrolidin-3-yl)-...)
Affinity DataIC50: 1.35nMAssay Description:LRRK2 kinase activity was measured using Lantha Screen technology from Invitrogen. GST-tagged truncated LRRK2 from Invitrogen (Cat #PV4874) was incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

LigandPNGBDBM551326(8-Chloro-1-(4,4-difluoro-1-methylpyrrolidin-3-yl)-...)
Affinity DataIC50: 2.35nMAssay Description:LRRK2 kinase activity was measured using Lantha Screen technology from Invitrogen. GST-tagged truncated LRRK2 from Invitrogen (Cat #PV4874) was incub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent